gene therapy
Showing 9976 - 10000 of >10,000
Temporomandibular Joint Dysfunction Syndrome Trial in Murcia (Manual therapy, Postural exercises)
Completed
- Temporomandibular Joint Dysfunction Syndrome
- Manual therapy
- Postural exercises
-
Murcia, SpainUniversity Of Murcia
Jun 8, 2023
Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)
Active, not recruiting
- Carcinoma, Hepatocellular
-
Los Angeles, California
- +138 more
Aug 22, 2022
Prostate Cancer Trial in United States (Degarelix, stereotactic body radiosurgery (SBRT))
Active, not recruiting
- Prostate Cancer
- Degarelix
- stereotactic body radiosurgery (SBRT)
-
Miami, Florida
- +9 more
Mar 1, 2022
Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed
Unknown status
- Hypothyroidism
- Hyperthyroidism
-
Bietigheim, BW, Germany
- +2 more
Oct 6, 2020
Eating Disorders Trial in London (Avatar Therapy)
Completed
- Eating Disorders
- Avatar Therapy
-
London, United KingdomKing's College London
Feb 28, 2022
Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)
Not yet recruiting
- Intra-cardiac Thrombus
- +2 more
- Vitamin K antagonist
- Direct oral anticoagulant
-
Angers, France
- +33 more
Apr 11, 2023
Lymphedema Arm Trial (BioBridge)
Not yet recruiting
- Lymphedema Arm
- BioBridge
- (no location specified)
Apr 20, 2023
Heart Failure Trial in Pointe-à-Pitre, Fort-de-France (Patient with no ventricular hypertrophy)
Not yet recruiting
- Heart Failure
- Patient with no ventricular hypertrophy
-
Pointe-à-Pitre, Guadeloupe
- +1 more
Aug 11, 2022
Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal
Completed
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +2 more
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation
Terminated
- Bladder Cancer
- +4 more
- 3D conformal radiation therapy
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 14, 2022
FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer
Completed
- FIGO Stage III and IV Ovarian Cancer
- +2 more
- ALT-803 Subcutaneous
- ALT-803 Intraperitoneal
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Oct 5, 2022
Immune Function and PD-1 Antibody Therapy Efficacy Predictors on
Recruiting
- Secondary Hemophagocytic Lymphohistiocytosis
- Chronic Active Epstein-Barr Virus Infection
- No intervention
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 2, 2023
PASS of Paediatric Patients Initiating Selumetinib
Recruiting
- Neurofibromatosis Type 1
-
Angers, France
- +3 more
Jan 12, 2023
NIAID Clinical Center Genomics Opportunity Protocol
Completed
- Immune Disorders
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
Depression, Anxiety, Stress Disorders, Post-Traumatic Trial in Winnipeg (MxN-9 HD-tES Stimulator (Soterix Inc.), Sham
Not yet recruiting
- Depression
- +2 more
- MxN-9 HD-tES Stimulator (Soterix Inc.)
- Sham Stimulation
-
Winnipeg, Manitoba, CanadaUniversity of Manitoba
Oct 31, 2022
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia
Recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
- +4 more
-
Milwaukee, WisconsinMedical College of Wisconsin
Sep 22, 2022
COVID-19 Pandemic Trial in Baghdad (Colchicine 0.5 MG)
Completed
- COVID-19 Pandemic
- Colchicine 0.5 MG
-
Baghdad, IraqUniversity of Baghdad
Nov 27, 2021
r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase
Not yet recruiting
- B-cell Lymphoma
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Aug 9, 2022
Breast Cancer Trial in Beijing (18F-FES PET/CT scan)
Recruiting
- Breast Cancer
- 18F-FES PET/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 4, 2022
Spinal Cord Injuries, Muscle Pareses, Fall Trial in Toronto (Activity-based rehabilitation+electrical stimulation)
Not yet recruiting
- Spinal Cord Injuries
- +2 more
- Activity-based rehabilitation+electrical stimulation
-
Toronto, Ontario, CanadaToronto Rehabilitation Institute-Lyndhurst Center
Jul 11, 2023
Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)
Completed
- Pancreas Cancer
- +6 more
-
Rozzano, Milan, ItalyIstituto Clinico Humanitas
Sep 9, 2022
Dementia, Dementia, Vascular, Dementia, Mixed Trial in London (Virtual Individual Cognitive Simulation Therapy)
Active, not recruiting
- Dementia
- +10 more
- Virtual Individual Cognitive Simulation Therapy
-
London, United KingdomUCL
Mar 24, 2022
Psoriasis Trial in Winston-Salem (transcutaneous electrical nerve stimulation (TENS) unit)
Active, not recruiting
- Psoriasis
- transcutaneous electrical nerve stimulation (TENS) unit
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jan 31, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, gemcitabin, cisplatin, Stereotactic Body Radiotherapy, Intensity
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab, gemcitabin, cisplatin
- Stereotactic Body Radiotherapy, Intensity modulated-radiotherapy
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jun 19, 2022
Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Carfilzomib 56 MG [Kyprolis]
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Aug 19, 2022